Skip to main content
Top
Published in: Digestive Diseases and Sciences 5/2022

08-04-2022 | Lymphoma | DDS–SIRC COOPERATIVE CONFERENCES

Duodenal Follicular Lymphoma: Track or Treat?

Authors: M. Varanese, A. Lauro, I. Lattina, D. Tripodi, T. Daralioti, S. Khouzam, I. R. Marino, V. Stigliano, V. D’Andrea, S. Frattaroli, S. Sorrenti

Published in: Digestive Diseases and Sciences | Issue 5/2022

Login to get access

Abstract

Duodenal follicular lymphoma (DFL) is a rare variety of non-Hodgkin’s lymphoma of the gastrointestinal tract that usually carries a favorable course, recognized as a new entity in 2016. It is usually diagnosed at an early stage located predominantly in the second portion of the duodenum. We report the case of a 74-year-old male patient with epigastric pain in whom gastroscopy revealed white mucosal nodules that were pathologically diagnosed as grade 1–2 DFL. Staging investigations revealed secondary lesions in the spleen and at the base of the tongue together with latero-cervical adenopathy. The tumor was stage IV according to the Lugano staging system. We reviewed the recent (last five years) literature defining the importance of combination therapy in the advanced stage. The patient achieved complete remission of the disease through chemoimmunotherapy following the Rituximab–Bendamustine scheme.
Literature
1.
go back to reference Hellmuth JC, Louissaint A, Szczepanowski M et al. Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles. Hematology Am Soc 2018;132:16. Hellmuth JC, Louissaint A, Szczepanowski M et al. Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles. Hematology Am Soc 2018;132:16.
2.
go back to reference Swerdlow SH, Campo E, Pileri SA et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016;127:20.CrossRef Swerdlow SH, Campo E, Pileri SA et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016;127:20.CrossRef
3.
go back to reference Takata K, Okada H, Ohmiya N et al. Primary gastrointestinal follicular lymphoma involving the duodenal second portion is a distinct entity a multicenter, retrospective analysis in Japan. Cancer Sci 2011;102:1532–1536.CrossRef Takata K, Okada H, Ohmiya N et al. Primary gastrointestinal follicular lymphoma involving the duodenal second portion is a distinct entity a multicenter, retrospective analysis in Japan. Cancer Sci 2011;102:1532–1536.CrossRef
4.
go back to reference Campo E, Swerdlow SH, Harris NL et al. The 2008 WHO classification of lymphoid neoplasms and beyond evolving concepts and practical applications. Blood 2011;117:19.CrossRef Campo E, Swerdlow SH, Harris NL et al. The 2008 WHO classification of lymphoid neoplasms and beyond evolving concepts and practical applications. Blood 2011;117:19.CrossRef
5.
go back to reference Tari A, Kitadai Y, Mouri R et al. Watch-and-wait policy versus rituximab-combined chemotherapy in Japanese patients with intestinal follicular lymphoma. J Gastroenterol Hepatol 2018;33:1461–1468.CrossRef Tari A, Kitadai Y, Mouri R et al. Watch-and-wait policy versus rituximab-combined chemotherapy in Japanese patients with intestinal follicular lymphoma. J Gastroenterol Hepatol 2018;33:1461–1468.CrossRef
6.
go back to reference Harada A, Oguchi M, Terui Y et al. Radiation therapy for localized duodenal low-grade follicular lymphoma. J Radiat Res 2016;57:412–417.CrossRef Harada A, Oguchi M, Terui Y et al. Radiation therapy for localized duodenal low-grade follicular lymphoma. J Radiat Res 2016;57:412–417.CrossRef
7.
go back to reference Cheson BD, Fisher RI, Barrington SF et al. Reccommendations for initial evaluation, staging and response assessment of Hodgkin and Non-Hodgkin lymphoma the Lugano classification. J Clin Oncol 2014;32:27.CrossRef Cheson BD, Fisher RI, Barrington SF et al. Reccommendations for initial evaluation, staging and response assessment of Hodgkin and Non-Hodgkin lymphoma the Lugano classification. J Clin Oncol 2014;32:27.CrossRef
9.
go back to reference Marks E, Shi Y. Duodenal-type follicular lymphoma. A clinic-pathological review. Arch Pathol Lab Med 2018; 142:542–547. Marks E, Shi Y. Duodenal-type follicular lymphoma. A clinic-pathological review. Arch Pathol Lab Med 2018; 142:542–547.
10.
go back to reference Dreyling M, Ghielmini M, Rule S et al. Newly diagnosed and relapsed follicular lymphoma ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2021;32:298–308.CrossRef Dreyling M, Ghielmini M, Rule S et al. Newly diagnosed and relapsed follicular lymphoma ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2021;32:298–308.CrossRef
11.
go back to reference Garrido I, Santos-Antunes J, Cardoso H, et al. Duodenal-type follicular lymphoma-a silent tumor. Rev Esp Enferm Dig 2021 Sep 14 (online ahead of print). Garrido I, Santos-Antunes J, Cardoso H, et al. Duodenal-type follicular lymphoma-a silent tumor. Rev Esp Enferm Dig 2021 Sep 14 (online ahead of print).
12.
go back to reference Silva JF, Morais R, Fonseca E, et al. A case of duodenal-type follicular lymphoma. Rev Esp Enferm Dig 2021 Sep 2 (online ahead of print). Silva JF, Morais R, Fonseca E, et al. A case of duodenal-type follicular lymphoma. Rev Esp Enferm Dig 2021 Sep 2 (online ahead of print).
13.
go back to reference Wu YL, Tsai YN, Wang WL. Magnifying observation of duodenal follicular lymphoma with chromoendoscopy and narrow-band imaging. Gastrointest Endosc 2021;94:1150–1151.CrossRef Wu YL, Tsai YN, Wang WL. Magnifying observation of duodenal follicular lymphoma with chromoendoscopy and narrow-band imaging. Gastrointest Endosc 2021;94:1150–1151.CrossRef
14.
go back to reference Charoenlap C, Akarapatima K, Suwanno K et al. Primary follicular lymphoma of the duodenum a case report and review of literatures. Gastroenterol Hepatol Bed Bench 2021;14:185–189.PubMedPubMedCentral Charoenlap C, Akarapatima K, Suwanno K et al. Primary follicular lymphoma of the duodenum a case report and review of literatures. Gastroenterol Hepatol Bed Bench 2021;14:185–189.PubMedPubMedCentral
15.
go back to reference Tanigawa T, Abe R, Kato J et al. Histological transformation in duodenal-type follicular lymphoma a case report and review of the literature. Oncotarget 2019;10:3424–3429.CrossRef Tanigawa T, Abe R, Kato J et al. Histological transformation in duodenal-type follicular lymphoma a case report and review of the literature. Oncotarget 2019;10:3424–3429.CrossRef
16.
go back to reference Giotis I, Tribonias G, Zacharopoulou E et al. A rare case of duodenal-type follicular lymphoma in rectum appearing as hyperplastic polyp with metachronous appearance in duodenum and stomach. Clin J Gastroenterol 2021;14:1632–1636.CrossRef Giotis I, Tribonias G, Zacharopoulou E et al. A rare case of duodenal-type follicular lymphoma in rectum appearing as hyperplastic polyp with metachronous appearance in duodenum and stomach. Clin J Gastroenterol 2021;14:1632–1636.CrossRef
17.
go back to reference Cencini E, Fabbri A, Mecacci B et al. Is bendamustine plus rituximab a suitable option for rituximab-refractory duodenal-type follicular lymphoma? Acta Gastroenterol Belg 2020;83:493.PubMed Cencini E, Fabbri A, Mecacci B et al. Is bendamustine plus rituximab a suitable option for rituximab-refractory duodenal-type follicular lymphoma? Acta Gastroenterol Belg 2020;83:493.PubMed
18.
go back to reference Nehme F, Rowe K, Palko W et al. Primary duodenal follicular lymphoma with late disseminated nodal relapse responsive to rituximab monotherapy A case report. Mol Clin Oncol 2017;7:911–914.CrossRef Nehme F, Rowe K, Palko W et al. Primary duodenal follicular lymphoma with late disseminated nodal relapse responsive to rituximab monotherapy A case report. Mol Clin Oncol 2017;7:911–914.CrossRef
19.
go back to reference Kiesewetter B, Dolak W, Mayerhoefer ME et al. Successful Clarithromycin Monotherapy in a Patient with Primary Follicular Lymphoma of the Duodenum. Case Rep Oncol 2018;11:239–245.CrossRef Kiesewetter B, Dolak W, Mayerhoefer ME et al. Successful Clarithromycin Monotherapy in a Patient with Primary Follicular Lymphoma of the Duodenum. Case Rep Oncol 2018;11:239–245.CrossRef
20.
go back to reference Takashi A, Kosuke K, Takayuki N et al. Follicular lymphoma Grade 1 of the minor duodenal papilla successfully diagnosed by endoscopic papillectomy. Endoscopy 2021;53:35–37. Takashi A, Kosuke K, Takayuki N et al. Follicular lymphoma Grade 1 of the minor duodenal papilla successfully diagnosed by endoscopic papillectomy. Endoscopy 2021;53:35–37.
21.
go back to reference Sato J, Ishiwatari H, Ashida R et al. Primary non-ampullary duodenal follicular lymphoma presenting with obstructive jaundice. Clin J Gastroenterol 2020;13:214–218.CrossRef Sato J, Ishiwatari H, Ashida R et al. Primary non-ampullary duodenal follicular lymphoma presenting with obstructive jaundice. Clin J Gastroenterol 2020;13:214–218.CrossRef
22.
go back to reference Nann D, Bonzheim I, Müller I et al. Clonally related duodenal-type follicular lymphoma and in situ follicular neoplasia. Haematologica 2019;104:537–539.CrossRef Nann D, Bonzheim I, Müller I et al. Clonally related duodenal-type follicular lymphoma and in situ follicular neoplasia. Haematologica 2019;104:537–539.CrossRef
23.
go back to reference Saburi M, Kondo Y, Ogata M et al. Development of diffuse large B-cell lymphoma from duodenal type follicular lymphoma a retrospective study of 23 cases. Int J Hematol 2020;112:658–665.CrossRef Saburi M, Kondo Y, Ogata M et al. Development of diffuse large B-cell lymphoma from duodenal type follicular lymphoma a retrospective study of 23 cases. Int J Hematol 2020;112:658–665.CrossRef
24.
go back to reference Abe R, Mori T, Tanigawa T et al. Clinical characteristics and outcomes of duodenaltype follicular lymphoma. Leuk Lymphoma 2020;61:3266–3268.CrossRef Abe R, Mori T, Tanigawa T et al. Clinical characteristics and outcomes of duodenaltype follicular lymphoma. Leuk Lymphoma 2020;61:3266–3268.CrossRef
25.
go back to reference Lee H, Oh D, Yang K et al. Radiation Therapy Outcome and Clinical Features of Duodenal-Type Follicular Lymphoma. Cancer Res Treat. 2019;5:547–555.CrossRef Lee H, Oh D, Yang K et al. Radiation Therapy Outcome and Clinical Features of Duodenal-Type Follicular Lymphoma. Cancer Res Treat. 2019;5:547–555.CrossRef
26.
go back to reference Inoue H, Rai S, Tanaka H et al. Tumour-immune microenvironment in duodenal-type follicular lymphoma. Br J Haematol 2020;191:243–252.CrossRef Inoue H, Rai S, Tanaka H et al. Tumour-immune microenvironment in duodenal-type follicular lymphoma. Br J Haematol 2020;191:243–252.CrossRef
27.
go back to reference Duffles Amarante G, Collins G, Rocha V. What do we know about duodenal-type follicular lymphoma? From pathological definition to treatment options. Br J Haematol 2020;188:831–837.CrossRef Duffles Amarante G, Collins G, Rocha V. What do we know about duodenal-type follicular lymphoma? From pathological definition to treatment options. Br J Haematol 2020;188:831–837.CrossRef
28.
go back to reference Schmatz AI, Streubel B, Kretschmer-Chott E et al. Primary follicular lymphoma of the duodenum is a distinct mucosal/submucosal variant of follicular lymphoma a retrospective study of 63 cases. J Clin Oncol 2011;29:1445–1451.CrossRef Schmatz AI, Streubel B, Kretschmer-Chott E et al. Primary follicular lymphoma of the duodenum is a distinct mucosal/submucosal variant of follicular lymphoma a retrospective study of 63 cases. J Clin Oncol 2011;29:1445–1451.CrossRef
29.
go back to reference Misdraji J, Harris NL, Hasserjian RP et al. Primary follicular lymphoma of the gastrointestinal tract. Am J Surg Pathol 2011;35:1255–1263.CrossRef Misdraji J, Harris NL, Hasserjian RP et al. Primary follicular lymphoma of the gastrointestinal tract. Am J Surg Pathol 2011;35:1255–1263.CrossRef
30.
go back to reference Mori M, Kobayashi Y, Maeshima AM et al. The indolent course and high incidence of t(14;18) in primary duodenal follicular lymphoma. Ann Oncol 2010;21:1500–1505.CrossRef Mori M, Kobayashi Y, Maeshima AM et al. The indolent course and high incidence of t(14;18) in primary duodenal follicular lymphoma. Ann Oncol 2010;21:1500–1505.CrossRef
31.
go back to reference Yanai S, Nakamura S, Takeshita M et al. Translocation t(14;18)/IGH-BCL2 in gastrointestinal follicular lymphoma correlation with clinicopathologic features in 48 patients. Cancer 2011;117:2467–2477.CrossRef Yanai S, Nakamura S, Takeshita M et al. Translocation t(14;18)/IGH-BCL2 in gastrointestinal follicular lymphoma correlation with clinicopathologic features in 48 patients. Cancer 2011;117:2467–2477.CrossRef
Metadata
Title
Duodenal Follicular Lymphoma: Track or Treat?
Authors
M. Varanese
A. Lauro
I. Lattina
D. Tripodi
T. Daralioti
S. Khouzam
I. R. Marino
V. Stigliano
V. D’Andrea
S. Frattaroli
S. Sorrenti
Publication date
08-04-2022
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 5/2022
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-022-07498-5

Other articles of this Issue 5/2022

Digestive Diseases and Sciences 5/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.